TYRA BIOSCIENCES INC's ticker is and the CUSIP is 90240B106. A total of 1 filers reported holding TYRA BIOSCIENCES INC in Q4 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $29,000 | -25.6% | 2,134 | -6.3% | 0.00% | – |
| Q2 2023 | $39,000 | +225.0% | 2,277 | +206.9% | 0.00% | – |
| Q1 2023 | $12,000 | -52.0% | 742 | -77.8% | 0.00% | – |
| Q4 2022 | $25,000 | +2400.0% | 3,344 | +1990.0% | 0.00% | – |
| Q3 2022 | $1,000 | 0.0% | 160 | +116.2% | 0.00% | – |
| Q2 2022 | $1,000 | -87.5% | 74 | -89.8% | 0.00% | – |
| Q1 2022 | $8,000 | -77.1% | 725 | -70.9% | 0.00% | – |
| Q4 2021 | $35,000 | – | 2,491 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Canaan Partners XI LLC | 4,409,991 | $31,531,000 | 11.23% |
| Nextech Invest Ltd. | 2,518,582 | $18,008,000 | 6.07% |
| Boxer Capital, LLC | 6,448,359 | $46,106,000 | 2.92% |
| TCG Crossover Management, LLC | 896,418 | $6,409,000 | 2.72% |
| Fairmount Funds Management LLC | 1,416,998 | $10,132,000 | 2.32% |
| RA Capital Management | 7,236,454 | $51,741,000 | 1.38% |
| Frazier Life Sciences Management, L.P. | 1,375,065 | $9,832,000 | 0.93% |
| BVF INC/IL | 2,472,327 | $17,677,000 | 0.85% |
| Sio Capital Management, LLC | 152,159 | $1,088,000 | 0.41% |
| Cormorant Asset Management, LP | 743,988 | $5,320,000 | 0.40% |